Actively Recruiting
Benefit of Permanent Stimulation of the Left Branch of the His Bundle Versus Right Ventricular Stimulation After Atrioventricular Node Ablation for Rapid Atrial Fibrillation
Led by University Hospital, Rouen · Updated on 2026-02-10
60
Participants Needed
1
Research Sites
182 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of the study is to evaluate the functional benefit of left bundle branch of His pacing compared to right ventricular pacing in patients implanted with a pacemaker prior to a atrioventricular node ablation procedure for rapid atrial fibrillation
CONDITIONS
Official Title
Benefit of Permanent Stimulation of the Left Branch of the His Bundle Versus Right Ventricular Stimulation After Atrioventricular Node Ablation for Rapid Atrial Fibrillation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pacemaker implanted patient with left bundle branch pacing lead and back-up right ventricular lead who underwent successful atrioventricular node ablation for rapid atrial fibrillation
- Atrioventricular node ablation performed less than 15 days ago
- Age 18 years or older
- Women of childbearing age using effective contraception for at least 1 month and during the study, with negative pregnancy test at inclusion
- Postmenopausal women with confirmed diagnosis (non-medically induced amenorrhea for at least 12 months prior to inclusion)
- Membership in a social security scheme
- Feasible patient follow-up
- Patient has read and understood the information leaflet and signed informed consent form
You will not qualify if you...
- Impaired autonomy preventing maximal cardiorespiratory effort test (VO2 max) under good conditions (ADL scale less than 5)
- Left ventricular ejection fraction less than 40% at inclusion
- Person deprived of liberty by administrative or judicial decision, or under court protection, sub-guardianship or curatorship
- Participation in another interventional trial
- History of illness or psychological or sensory abnormality likely to prevent understanding or informed consent
- Pregnant, parturient, or breastfeeding women, or women without proven contraception
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU de CAEN
Caen, France
Actively Recruiting
Research Team
C
Corentin CHAUMONT, MD
CONTACT
A
Armelle GUIDOTTI
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here